Literature DB >> 8189255

Quality of long-term survival in young children with medulloblastoma.

D L Johnson1, M A McCabe, H S Nicholson, A L Joseph, P R Getson, J Byrne, C Brasseux, R J Packer, G Reaman.   

Abstract

The reported success of treatment for children with medulloblastoma must be balanced against the effect that treatment has on the quality of life of long-term survivors. The outcome of long-term survivors reported in previous studies has been conflicting. The authors evaluate the mental and behavioral skills of a group of medulloblastoma survivors from their institution, all of whom had survived for more than 5 years postdiagnosis. A review of the institutional records yielded 32 patients. Twenty-three families were interviewed by telephone and, of these, 13 subjects came to the hospital for detailed neuropsychological and neurological evaluations. Intelligence quotient (IQ) was less than 90 for all participants tested, and patients diagnosed before the age of 3 years had lower IQ scores on average than those diagnosed later. Mean IQ and achievement test scores in reading, spelling, and mathematics were all higher in survivors who had undergone shunting. Achievement test results were often not in accord with intellectual potential, and individual intellectual skills varied widely. Perceptual-motor task performance was below average in more than 50% of the participants, but motor dexterity was more severely affected than perception. Problems in learning and a delay in both physical growth and development were seen in a majority of participants. This study directs attention to the serious difficulties faced by long-term survivors of medulloblastoma and their families, and underscores the importance of routine neuropsychological testing. Moreover, the study provides further impetus to seek alternatives to irradiation in the treatment of malignant brain tumors.

Entities:  

Mesh:

Year:  1994        PMID: 8189255     DOI: 10.3171/jns.1994.80.6.1004

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  28 in total

1.  Neurological dysfunction associated with postoperative cerebellar mutism.

Authors:  J Siffert; T Y Poussaint; L C Goumnerova; R M Scott; B LaValley; N J Tarbell; S L Pomeroy
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003.

Authors:  D Kombogiorgas; S Sgouros; A R Walsh; A D Hockley; M Stevens; R Grundy; A Peet; M English; D Spooner
Journal:  Childs Nerv Syst       Date:  2006-11-22       Impact factor: 1.475

3.  Dose-volume metrics and their relation to memory performance in pediatric brain tumor patients: A preliminary study.

Authors:  Kimberly P Raghubar; Michael Lamba; Kim M Cecil; Keith Owen Yeates; E Mark Mahone; Christina Limke; David Grosshans; Travis J Beckwith; M Douglas Ris
Journal:  Pediatr Blood Cancer       Date:  2018-06-01       Impact factor: 3.167

Review 4.  Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review.

Authors:  Thora Gudrunardottir; Birgitta Lannering; Marc Remke; Michael D Taylor; Elizabeth M Wells; Robert F Keating; Roger J Packer
Journal:  Childs Nerv Syst       Date:  2014-02-26       Impact factor: 1.475

5.  Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro.

Authors:  R J Macaulay; W Wang; J Dimitroulakos; L E Becker; H Yeger
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

6.  Challenges in the management of childhood low-grade glioma in a developing country.

Authors:  Khalid Abdalla; Shaker Abdullah; Abeer Almehdar; Naglla Elimam; Mohammed Burhan Abrar; Wasil Jastaniah
Journal:  Childs Nerv Syst       Date:  2018-02-02       Impact factor: 1.475

7.  Neuropsychological sequelae of the treatment of children with medulloblastoma.

Authors:  M Dennis; B J Spiegler; C R Hetherington; M L Greenberg
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

8.  Maternal and perinatal risk factors for childhood brain tumors (Sweden).

Authors:  M S Linet; G Gridley; S Cnattingius; H S Nicholson; U Martinsson; B Glimelius; H O Adami; M Zack
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

9.  Adverse medical events associated with childhood cerebellar astrocytomas and medulloblastomas: natural history and relation to very long-term neurobehavioral outcome.

Authors:  Caroline Roncadin; Maureen Dennis; Mark L Greenberg; Brenda J Spiegler
Journal:  Childs Nerv Syst       Date:  2008-06-25       Impact factor: 1.475

Review 10.  Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

Authors:  Sharon M Castellino; Nicole J Ullrich; Megan J Whelen; Beverly J Lange
Journal:  J Natl Cancer Inst       Date:  2014-07-30       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.